CD27 peptide
CD27 peptide is a 13-amino acid peptide derived from CD27. CD27 peptide is a targeting ligand for CD70 and can be used to construct CD70-targeted peptide amphiphile micelles. CD27 peptide can be used for research on melanoma and clear cell renal cell carcinoma.
For research use only. We do not sell to patients.
- CAS No.: 3037125-72-4
- Formula: C54H92N18O17S3
- Molecular Weight:1361.61
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
In Vivo
-
Animal Model:C57BL/6 (Female human CD27 transgenic (hCD27), aged 6-12 weeks)[2]
-
Dosage:100 µg
-
Administration:i.p.; on days 3 and 6 after tumor implantation
-
Result:Increased Ova(I)-specific CD8+ T cells from ~20% to ~50% of the CD8+ TIL population.
Extended median survival by 18 days compared to control animals.\nProlonged survival in the setting of vaccines comprised of linked class I and II epitopes (Ova(I-IIA)).
Had no effect on survival with Ova(I) or Ova(I) + Ova(IIA) vaccines.\nProlonged survival in hCD27 mice bearing intracranial B16.OVA tumors.
-
Animal Model:C57BL/6 (Female human CD27 transgenic (hCD27), aged 6-12 weeks)[2]
-
Dosage:100 µg
-
Administration:i.p.; on days 3 and 6 after tumor implantation
-
Result:Prolonged survival in mice bearing 3-day established intracranial B16.F10 tumors when combined with Trp2(I)-P30.
Had no effect on survival relative to control groups when combined with Trp2(I).
Chemical Information
-
CAS No. 3037125-72-4
-
Molecular Weight 1361.61
-
Formula C54H92N18O17S3
-
Sequence
Cys-Arg-Lys-Ala-Ala-Gln-Cys-Asp-Pro-Cys-Ile-Pro-Gly
-
Sequence Shortening
CRKAAQCDPCIPG
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)